DTM™ SCS endurance therapy Spinal cord stimulation
DTM™ SCS endurance therapy is a spinal cord stimulation (SCS) therapy available to treat patients with chronic, intractable pain.
Access clinical postersYour browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
DTM™ SCS endurance therapy is a spinal cord stimulation (SCS) therapy available to treat patients with chronic, intractable pain.
Access clinical postersInspired by science
DTM™ SCS therapy options are inspired by decades of basic science research and preclinical understanding. In a preclinical study, the DTM™ programming (DTMP) derivatives modulated neuro-inflammatory processes more than low-rate SCS.*2
Clinical results show meaningful pain relief
Study objectives
DTM™ SCS endurance therapy study is a prospective, multicenter, single-arm study designed to evaluate the long-term efficacy and energy use of DTM™ SCS endurance therapy.1
Primary objective: To evaluate the effectiveness of DTM™ SCS endurance therapy in reducing overall pain intensity at 3-months follow up.
Secondary objectives with follow up to 12-months:
12-Month Outcomes
Meaningful
pain relief
4.6
cm reduction in VAS for overall pain
from baseline to 12 months1
Mean overall VAS
Note: *Subjects were excluded from analysis at 6-Months due to programming changes from DTMTM SCS endurance therapy (N=1) and due to study exit (N=1). **Subjects were excluded from analysis at 12-Months due to programming changes from DTMTM SCS endurance therapy (N=2) and due to study exit (N=1)
Meaningful quality of
life improvements
76%
of patients improved in degree of disability
at 12-month follow up1
Meaning ODI scores
Therapy satisfaction
86%
of patients were
satisfied with therapy1
Long lasting
5½-7½
years of recharge-free longevity
estimated using actual
12-month programming data3
Save time
5 minutes
estimated daily rapid recharge
or recharge less frequently
(1 hour every 12 days)3
DTM™ SCS offers proven pain relief backed by data on Intellis™ SCS. Learn about the therapy.
See DTM™ SCSHigh performance and recharge free. Experience DTM™ SCS endurance therapy on Vanta™.
Rapid recharge available with DTM™ SCS or DTM™ SCS endurance therapy.
*Note: Data obtained from animal studies should not be extrapolated to clinical/human results.
Provenzano, Peacock, Fishman, et al. A prospective multi-center study of a reduced-energy DTM™ stimulation derivative: Long-term outcomes in therapy naïve patients. Poster presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Pain Medicine Meeting; Nov. 17–19, 2022; Orlando, FL, USA.
Cedeno D, Vallejo R, Platt D, et al. Differential target multiplexed SCS using reduced energy parameters in an animal model of neuropathic pain. Poster presented at: American Society of Pain and Neuroscience (ASPN) annual meeting. July 22&nash;25, 2021.
Provenzano, Amirdelfan, Grewal, et al. Modeling energy demands of a reduced-energy derivative of DTM™ stimulation on rechargeable and recharge-free SCS systems. Poster presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Pain Medicine Meeting; Nov. 17–19, 2022; Orlando, FL, USA.